S&P 500
(0.12%) 5 303.27 points

Dow Jones
(0.34%) 40 004 points

Nasdaq
(-0.07%) 16 686 points

Oil
(-0.04%) $80.03

Gas
(1.56%) $2.67

Gold
(0.80%) $2 436.80

Silver
(3.78%) $32.44

Platinum
(0.93%) $1 100.10

USD/EUR
(-0.08%) $0.919

USD/NOK
(-0.05%) $10.67

USD/GBP
(0.01%) $0.787

USD/RUB
(0.09%) $91.05

Realtime updates for CEL-SCI Corp [CVM]

Exchange: AMEX Industry: Biotechnology

Last Updated17 May 2024 @ 16:00

25% discount on Stockinvest.us - Use code: Podcast

-9.29% $ 1.270

Live Chart Being Loaded With Signals

Commentary (17 May 2024 @ 16:00):

CEL-SCI Corporation engages in the research and development of immunotherapy for the treatment of cancer and infectious diseases. The company's lead investigational immunotherapy is Multikine, which is under phase III clinical trial for the treatment of head and neck cancer...

Stats
Today's Volume	464 189
Average Volume	361 633
Market Cap	68.78M
EPS	$-0.140 ( 2024-05-17 )
Next earnings date	( $-0.130 ) 2024-08-09
Last Dividend	$0.250 ( 1996-08-28 )
Next Dividend	$0 ( N/A )
P/E	-1.840
ATR14	$0.00800 (0.62%)

Insider Trading

Date	Person	Action	Amount	type
2024-05-08	Watson Robert Eugene	Buy	20 000	Common Stock
2024-05-08	Prichep Patricia B	Buy	8 000	Common Stock
2024-05-08	Kersten Geert R	Buy	30 000	Common Stock
2024-04-19	Gobbo Mario	Sell	0	Common Stock
2024-04-19	Gobbo Mario	Sell	64 000	Options

INSIDER POWER
90.94
Last 100 transactions
Buy: 5 675 210 \| Sell: 153 000

Volume Correlation

Long: -0.37 (neutral)

Short: 0.76 (moderate)

Signal:(53.471) Neutral

CEL-SCI Corp Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

CEL-SCI Corp Correlation - Currency/Commodity

-0.87
( strong negative )

-0.87
( strong negative )

0.00
( neutral )

-0.91
( very strong negative )

0.00
( neutral )

0.79
( moderate )

CEL-SCI Corp Financials

Annual	2023
Revenue:	$0
Gross Profit:	$-3.96M (0.00 %)
EPS:	$-0.720

FY	2023
Revenue:	$0
Gross Profit:	$-3.96M (0.00 %)
EPS:	$-0.720

FY	2022
Revenue:	$0
Gross Profit:	$-3.88M (0.00 %)
EPS:	$-0.890

FY	2021
Revenue:	$0.00
Gross Profit:	$0.00 (0.00 %)
EPS:	$-0.900

Financial Reports:

No articles found.

CEL-SCI Corp Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

CEL-SCI Corp Dividend Information - No Dividend Player

Dividend Sustainability Score: 0 - N/A | Divividend Growth Potential Score: 0 - N/A

Information

First Dividend	$0.250	1996-08-28
Last Dividend	$0.250	1996-08-28
Next Dividend	$0	N/A
Payout Date	2017-06-15
Next Payout Date	N/A
# dividends	1	--
Total Paid Out	$0.250	--
Avg. Dividend % Per Year	0.00%	--
Score	0.01	--
Div. Sustainability Score	0
Div.Growth Potential Score	0
Div. Directional Score	0	--

Next Divdend (Est)
(2024-05-20)

$0 Estimate 0.00 %

Dividend Stability

0.00 Very Bad

Dividend Score

0.01

Pay Frequency

Insufficient data to determine frequency

Yearly Payout

Year	Amount	Yield

Dividend Commentary

Unable to generate commentary due to missing data.

Top 10 dividend Companies for AMEX

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend	Score
DIT	Ex Dividend Knight	2023-08-03	Bi-Monthly	0	0.00%
JAVA	Ex Dividend Junior	2023-09-19	Bi-Monthly	0	0.00%
QSWN	Ex Dividend Junior	2023-06-28	Quarterly	0	0.00%
HJEN	Ex Dividend Junior	2023-09-19	Quarterly	0	0.00%
PCG-PH	Ex Dividend Junior	2023-07-28	Annually	0	0.00%
CTO	Ex Dividend Knight	2023-09-13	Quarterly	0	0.00%
FTF	Ex Dividend King	2023-09-15	Monthly	0	0.00%
NHS	Ex Dividend King	2023-08-14	Monthly	0	0.00%
CIK	Ex Dividend King	2023-09-18	Monthly	0	0.00%
EVM	Ex Dividend Knight	2023-09-21	Monthly	0	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0	1.500	0	0	[0 - 0.5]
returnOnAssetsTTM	-0.997	1.200	-10.00	-10.00	[0 - 0.3]
returnOnEquityTTM	-2.18	1.500	-10.00	-10.00	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	1.673	0.800	6.63	5.31	[1 - 3]
quickRatioTTM	1.044	0.800	8.57	6.85	[0.8 - 2.5]
cashRatioTTM	1.044	1.500	5.31	7.97	[0.2 - 2]
debtRatioTTM	0.420	-1.500	2.99	-4.49	[0 - 0.6]
interestCoverageTTM	-77.16	1.000	-10.00	-10.00	[3 - 30]
operatingCashFlowPerShareTTM	-0.387	2.00	-0.129	-0.258	[0 - 30]
freeCashFlowPerShareTTM	-0.392	2.00	-0.196	-0.392	[0 - 20]
debtEquityRatioTTM	0.883	-1.500	6.47	-9.70	[0 - 2.5]
grossProfitMarginTTM	0	1.000	-3.33	-3.33	[0.2 - 0.8]
operatingProfitMarginTTM	0	1.000	-2.00	-2.00	[0.1 - 0.6]
cashFlowToDebtRatioTTM	-1.593	1.000	-9.96	-9.96	[0.2 - 2]
assetTurnoverTTM	0	0.800	-3.33	-2.67	[0.5 - 2]
Total Score				-1.829

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	-2.21	1.000	-0.324	0	[1 - 100]
returnOnEquityTTM	-2.18	2.50	-10.00	-10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	-0.392	2.00	-0.131	-0.392	[0 - 30]
dividendYielPercentageTTM	0	1.500	0	0	[0 - 0.4]
operatingCashFlowPerShareTTM	-0.387	2.00	-0.129	-0.258	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	-0.0440	1.500	-3.63	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0	1.000	-2.50	0	[0.1 - 0.5]
Total Score				-1.878

CEL-SCI Corp Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

CEL-SCI Corp

CEL-SCI Corporation engages in the research and development of immunotherapy for the treatment of cancer and infectious diseases. The company's lead investigational immunotherapy is Multikine, which is under phase III clinical trial for the treatment of head and neck cancer. Its Ligand Epitope Antigen Presentation System (LEAPS), a pre-clinical patented T-cell modulation process that stimulates the human immune system to fight bacterial, viral, and parasitic infections, as well as autoimmune diseases, allergies, transplantation rejections, and cancer. The company also develops LEAPS-H1N1-DC; CEL-2000 and CEL-4000 are product candidates for the treatment of rheumatoid arthritis; and LEAPS COV-19, a product candidate to treat COVID-19 coronavirus. CEL-SCI Corporation has a collaboration agreement with the University of Georgia's Center for Vaccines and Immunology to develop LEAPS COVID-19 immunotherapy. The company was incorporated in 1983 and is headquartered in Vienna, Virginia.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators

Investing in the stock market involves risk and the value of your investment can fluctuate. The stock market can be affected by a variety of factors, including economic conditions, company performance, and global events. There is no guarantee of profit and you could lose money. Please consider your financial situation, investment goals, and level of risk tolerance before making any investment decisions. Consult with a financial advisor for personalized advice.